Podcasts about fapi

In deze podcast gaat prof. dr. Lioe-Fee de Geus-Oei, nucleair geneeskundige aan het Leids Universitair Medisch Centrum te Leiden, in gesprek met dr. Andor van den Hoven, nucleair radioloog in het St. Antonius Ziekenhuis te Nieuwegein, onderzoeker en voorzitter van de FAPI-werkgroep. Ze bespreken de ontwikkelingen rond de veelbelovende nieuwe tracer voor theranostische toepassingen: fibroblast activation protein inhibitor, oftewel FAPI. Het gesprek gaat over de moleculair-biologische eigenschappen van deze tracer, de indicaties waarbij FAPI-PET/CT mogelijk meerwaarde kunnen bieden, de lopende studies op dit gebied in Nederland, de verwachtingen met betrekking tot radionuclidentherapie, de activiteiten van de landelijke FAPI-werkgroep en de toekomstperspectieven van deze nieuwe theranostische aanpak.

This Videocast episode explores the complexities and advancements in digital identity standards, focusing on FAPI, OAuth, and OpenID Connect. Martin Kuppinger and Joseph Heenan, CTO of Authlete, discuss the origins and purpose of FAPI, its adoption across various regions, and its significance in enhancing security and interoperability in financial services. They also highlight the role of Authlete in simplifying the implementation of these standards for developers and the emerging trends in decentralized identity and verifiable credentials.

This Videocast episode explores the complexities and advancements in digital identity standards, focusing on FAPI, OAuth, and OpenID Connect. Martin Kuppinger and Joseph Heenan, CTO of Authlete, discuss the origins and purpose of FAPI, its adoption across various regions, and its significance in enhancing security and interoperability in financial services. They also highlight the role of Authlete in simplifying the implementation of these standards for developers and the emerging trends in decentralized identity and verifiable credentials.

FAPI is a refinement of the OAuth standard developed by the OpenID Foundation. It was conceived to solve a core problem of providing a consistent approach to API security across the financial industry, with the goal of enhancing interoperability of financial data exchange. It has now been adopted across many different industries in applications where The post Enhancing OAuth Security and Interoperability Using FAPI with Joseph Heenan appeared first on Software Engineering Daily.

FAPI is a refinement of the OAuth standard developed by the OpenID Foundation. It was conceived to solve a core problem of providing a consistent approach to API security across the financial industry, with the goal of enhancing interoperability of financial data exchange. It has now been adopted across many different industries in applications where The post Enhancing OAuth Security and Interoperability Using FAPI with Joseph Heenan appeared first on Software Engineering Daily.

Alfredo Cecchi Presidente de Fapi @conexionparques 28-12-2023

What is it with FAPI and how does it work? In this episode of Theragnostic Talks, we take a closer look at the tracer that everyone's talking about. The new theragnostic tracer targets the tumour environment and can be used for both the diagnosis and treatment of a wide range of different types of cancers. Explaining this are Dr. Wolfgang Fendler, Prof. Thomas Hope, Kim M. Pabst, and Silvi Telo.   Guests: Dr. Wolfgang Fendler, Prof. Thomas Hope, Kim M. Pabst, and Silvi Telo. By: Gustav Widar, Medical Affairs Manager Contact us: podcast@samnordic.se For more information, visit: www.samnordic.se

Ratio Therapeutics  with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed beforehttps://ratiotx.com/ #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Ratio Therapeutics with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed beforehttps://ratiotx.com/  #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Ratio Therapeutics with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed beforehttps://ratiotx.com/  #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Ratio Therapeutics  with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed beforehttps://ratiotx.com/ #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Ratio Therapeutics  with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed beforehttps://ratiotx.com/  #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Episode 152:     Welcome to PI-Perspectives. This week Matt welcomes Harvey Morse. Harvey is the expert on Genealogical research and has worked on some real high-profile cases. His family has been in the business over 3 generations. Harvey also formed FAPI, The Florida Association on Professional Investigators. They have a great Free conference coming up at the end of the month. Please welcome Harvey Morse and your host, private Investigator, Matt Spaier  Links:      Matt's email: MatthewS@Satellitepi.com   Linkedin: Matthew Spaier       www.investigators-toolbox.com   PI-Perspectives Youtube link:  https://www.youtube.com/channel/UCYB3MaUg8k5w3k7UuvT6s0g Harvey email: harvey@probate.com Harvey on Linkedin: Harvey Morse https://www.bestpi.com/harveyemorse https://www.myfapi.org/2022-Conference Sponsors:     https://apps.crosstrax.co/signup/index/refcd/LY3R7VUW69 https://irbfocus.com/Rosa/apply?UTM_SOURCE=PI_Perspectives&UTM_MEDIUM=Podcast&UTM_CAMPAIGN=Investigtive&UTM_CONTENT=Evergreen_Leads https://orep.org/private-investigator-insurance/ https://www.tali.org/ https://investigationeducation.com/

SNMMI Image of the YEAR 2022! Johanna DiekmannSNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling after Heart Attack.We talk to Johanna Diekmann about a novel use of this new versatile tracer. FAPI.when correlated with cardiac MRI, 68Ga-FAPI-46 PET is new specific indicator of active fibrosis and can identify a patient's chances of recovery. The detailed depiction of 68Ga-FAPI-46 PET signal after acute anterior myocardial infarction has been selected as SNMMI's 2022 Image of the Year.https://www.xcdsystem.com/snmmi/program/2ATlJc8/index.cfm?pgid=237&qfixed=1&sessiontype=Cardiovascularhttps://www.nuccast.com Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #cardiac #tracers #Hannover#fibrosisNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, cardiac, tracers, Hannover, fibrosis@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

SNMMI Image of the YEAR 2022! Johanna DiekmannSNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling after Heart Attack.We talk to Johanna Diekmann about a novel use of this new versatile tracer. FAPI.when correlated with cardiac MRI, 68Ga-FAPI-46 PET is new specific indicator of active fibrosis and can identify a patient's chances of recovery. The detailed depiction of 68Ga-FAPI-46 PET signal after acute anterior myocardial infarction has been selected as SNMMI's 2022 Image of the Year.https://www.xcdsystem.com/snmmi/program/2ATlJc8/index.cfm?pgid=237&qfixed=1&sessiontype=Cardiovascularhttps://www.nuccast.com  Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #cardiac #tracers #Hannover#fibrosis  Nuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, cardiac, tracers, Hannover, fibrosis@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

SNMMI Image of the YEAR 2022! Johanna DiekmannSNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling after Heart Attack.We talk to Johanna Diekmann about a novel use of this new versatile tracer. FAPI.when correlated with cardiac MRI, 68Ga-FAPI-46 PET is new specific indicator of active fibrosis and can identify a patient's chances of recovery. The detailed depiction of 68Ga-FAPI-46 PET signal after acute anterior myocardial infarction has been selected as SNMMI's 2022 Image of the Year.https://www.xcdsystem.com/snmmi/program/2ATlJc8/index.cfm?pgid=237&qfixed=1&sessiontype=Cardiovascularhttps://www.nuccast.com Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #cardiac #tracers #Hannover#fibrosisNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, cardiac, tracers, Hannover, fibrosis@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

SNMMI Image of the YEAR 2022! Johanna DiekmannSNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling after Heart Attack.We talk to Johanna Diekmann about a novel use of this new versatile tracer. FAPI.when correlated with cardiac MRI, 68Ga-FAPI-46 PET is new specific indicator of active fibrosis and can identify a patient's chances of recovery. The detailed depiction of 68Ga-FAPI-46 PET signal after acute anterior myocardial infarction has been selected as SNMMI's 2022 Image of the Year.https://www.xcdsystem.com/snmmi/program/2ATlJc8/index.cfm?pgid=237&qfixed=1&sessiontype=Cardiovascularhttps://www.nuccast.com Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #cardiac #tracers #Hannover#fibrosisNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, cardiac, tracers, Hannover, fibrosis@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Discurso: governador Rodrigo Garcia na abertura da Fapi em Ourinhos 04/06/22 by Governo do Estado de São Paulo

Coletiva: governador Rodrigo Garcia na Fapi em Ourinhos 04/06/22 by Governo do Estado de São Paulo

Biblioteca Antonieta de Barros Conta e Canta: "Coração de Pedra". --- Send in a voice message: https://anchor.fm/ebm-tapera/message

ZOOM - 90 MINUTI IN MEZZO AI FATTI - A. D'ANNA - P. D'AMICO - A. TORREGIANI, 19-1-22 h. 10.35 Alberto Torregiani, rimasto ferito nell'attentato che nel 1979 costò la vita a suo padre Pierluigi, parla con Antonino D'Anna: dal suo impegno per i diversamente abili con la FAPI al suo libro "Ero in guerra e non lo sapevo", che è diventato un flm in programma in diverse sale italiane dal 24 al 26 gennaio. Alle 10.42 Paola D'Amico sarà "L'amica degli animali": si parla di squali! Diretta dalle 10.35 del 19 gennaio THE BEST IS YET TO COME!

ZOOM – 90 MINUTI IN MEZZO AI FATTI – A. D’ANNA – P. D’AMICO – A. TORREGIANI, 19-1-22 h. 10.35 Alberto Torregiani, rimasto ferito nell’attentato che nel 1979 costò la vita a suo padre Pierluigi, parla con Antonino D’Anna: dal suo impegno per i diversamente abili con la FAPI al suo libro “Ero in guerra e non lo sapevo”, che è diventato un flm in programma in diverse sale italiane dal 24 al 26 gennaio. Alle 10.42 Paola D’Amico sarà “L’amica degli animali”: si parla di squali! Diretta dalle 10.35 del 19 gennaio THE BEST IS YET TO COME!

Let's talk about digital identity with Nat Sakimura, Chairman at the OpenID Foundation. In episode 59, Nat returns to the podcast to explore Financial-Grade API (FAPI), the base security protocol for UK Open Banking, Australian Consumer Data Standard, and Brazil's Open Banking. He discusses why and how FAPI was formed; what exactly FAPI is – including technical characteristics; how FAPI is used today; and future plans for the specification - as well as how it connects to GAIN. [Transcript below] "The data economy needs a secure and interoperable data network. And we are finally getting there with FAPI and eKYC standards. So, you guys need to get ready for the ride. It's the time. You need to start acting, start preparing for that." Nat Sakimura is a well-known identity and privacy standardisation architect and the representative partner of NAT Consulting. Besides being an author/editor of such widely used standards as OpenID Connect, FAPI, JWT (RFC7519), JWS (RFC7515), OAuth PKCE (RFC7636) ISO/IEC 29184, ISO/IEC 29100 Amd.1, he helps communities to organise themselves to realise the ideas around identity and privacy. As the chairman of the board of the OpenID Foundation, he streamlined the process, bolstered the IPR management, and greatly expanded the breadth of the Foundation spanning over 10 working groups whose members include large internet services, mobile operators, financial institutions, governments, etc. He is also active in the public policy space. He has been serving in various committees in the Japanese government, including the Study Group on the Platform Services of the Ministry of Internal Affairs and Communications and the Study Group on the competition in Digital Market of the Fair Trade Commission of Japan. Find Nat on Twitter @_nat_en and LinkedIn. Nat also appeared in episode 54 of Let's Talk About Digital Identity, discussing how OpenID Connect took over the world. We'll be continuing this conversation on Twitter using #LTADI – join us @ubisecure!     Podcast transcript Let's Talk About Digital Identity, the podcast connecting identity and business. I am your host, Oscar Santolalla. Oscar Santolalla: Hello and welcome to the first episode of Let's Talk About Digital Identity for this New Year 2022. And we have a very special guest who has been in very short clips in an episode we had in October, very recently in October. A very special episode, a storytelling episode called How OpenID Connect took over the World, and today's guest was there. We are talking about our super special guest called Nat Sakimura, one of the creators of the OpenID Connect standard. Nat Sakimura is a well-known identity and privacy standardisation architect and a representative partner of NAT Consulting. Besides being an author and editor of such widely standards such as the OpenID Connect, FAPI, JWT, OAuth PKCE among others, he helps communities to organise themselves to realise the ideas around identity and privacy. As the chairman of the board of the OpenID Foundation, he streamlined the process, bolstered the IPR management, and greatly expanded the breadth of the Foundation spanning over 10 working groups whose members included large internet services, mobile operators, financial institutions, government, etc. He has been serving in various committees in the Japanese government, including a Study Group on the Platform Services of the Ministry of Internal Affairs and Communications and a Study Group on the competition in Digital Market of the Fair-Trade Commission of Japan. Hello, Nat. Nat Sakimura: Hi, Oscar. Thanks for inviting me. Oscar: Welcome. It's a great pleasure talking with you, Nat. And well, Happy New Year. And let's talk about digital identity. Nat: Likewise, yeah. Oscar: Fantastic. And I think we know a lot of your involvement, of course, you are leading one of the most important standardisation organisations in the digital space.

In this Breaking Changes tl;dr mini-episode, Postman Chief Evangelist Kin Lane welcomes yes® CTO Torsten Lodderstedt to get key insights about the identity layer, including OAuth, OpenID, and FAPI.   

The issue in dispute is whether, during the 2001 to 2005 and 2008 and 2010 taxation years, the income of Glenhuron Bank Limited (“GBL”), a bank licenced in Barbados, was foreign accrual property income (“FAPI”) pursuant to ss. 91 and 95 of the Act. If so, the taxable income of Loblaw Financial Holdings Inc. in Canada must include a percentage of its affiliate's FAPI equivalent to the participating percentage of the respondent's shares in GBL. FAPI includes income from an investment business. The definition of investment business in s. 95(1) of the Act exempts a business, other than a business conducted principally with non-arm's length persons, of a regulated foreign bank with greater than five full-time employees. The respondent appealed its tax reassessments on the basis that as GBL was a regulated foreign bank that met the added conditions, its income for the taxation years in question was not FAPI. The appellant argued that GBL was not a foreign bank, did not have greater that five full time employees and was not conducting business principally with non-arm's length persons, since it was not in competition with anyone. The Crown also argued that the general anti-avoidance rule applied to a series of transactions by the respondent and GBL to give the appearance of compliance with the “investment business” exception. The Tax Court allowed the respondent's appeals in part, holding that the foreign exchange gains or losses arising on GBL's investment in short term securities should be on income account. However, the Court determined that while GBL is a regulated foreign bank with more than the equivalent of five full time employees, it was conducting business principally with related persons and therefore could not benefit from the financial institution exemption from investment business. It found, in obiter, that there had been no tax avoidance transactions. The Federal Court of Appeal allowed the respondent's appeal, set aside the decision of the Tax Court, and referred the reassessment back to the Minister for reconsideration and reassessment on the basis that GBL's FAPI consists only of income from investment management services provided to non-arm's length parties. In its view, the receipts side of banking should not be considered when determining whether the investment business was conducted principally with non-arm's length parties. Keywords Taxation - Income tax, Legislation, Interpretation - Taxation - Income tax - Tax avoidance - Legislation - Interpretation - Interpretation of foreign accrual property income provisions - Whether the business of the respondent's foreign affiliate as a foreign bank was conducted principally with persons with whom it does not deal at arm's length - Did the Federal Court of Appeal err in its interpretation of the definition of “investment business” in s. 95(1) of the Income Tax Act, particularly the phrase other than any business conducted principally with persons with whom the affiliate does not deal at arm's length in the financial institution exception- Income Tax Act, R.S.C. 1985, c. 1 (5th Supp) ss. 91 and 95. Notes (Federal Court) (Civil) (By Leave) Disclaimers This podcast is created as a public service to promote public access and awareness of the workings of Canada's highest court. It is not affiliated with or endorsed by the Court. The original version of this hearing may be found on the Supreme Court of Canada's website. The above case summary was prepared by the Office of the Registrar of the Supreme Court of Canada (Law Branch).

O nosso convidado de hoje é o Alexandre Judkiewicz . Alexandre é formado em gestão de marketing pela Universidade Paulista, tem especialização em Gestão de Pessoas pela FGV, MBA em Estratégia em Segurança Empresarial pela Anhembi Morumbi, Extensão Universitária em Investigação de Fraudes pela FAPI, é coach certificado pelo ICC, tem Especialização em Contabilidade e Finanças pela FGV, pós graduação in company em Gestão de Shopping Centers pela Fundação Dom Cabral e curso de certificação para Green Belt pela Fundação Vanzolini. Na sua jornada profissional já foi auxiliar de segurança da Federação Israelita do Estado de SP, Vigiliante, Supervisor, VSPP e Coordenador no Colégio I.L. Peretz, Gerente de Segurança Patrimonial na Usiminas, Gerente de Segurança no Shopping Center Iguatemi São Paulo, Gerente Corporativo de Segurança da Rrede Iguatemi e da rede Sarah, diretor de operações e qualidade do Grupo GR e diretor executivo na Federação Israelita do Estado de SP. Atualmente é empreendedor, fundador da AJUD Security Intelligence, co-autor do livro Operações em Shopping Centers e Autor do livro Planejamento e Gestão de Segurança em Shopping Centers. Envie o seu áudio para o Whatsapp:(11) 9 8987-7715 e participe conosco, falando sobre o que mais gostou nesse episódio, sugerindo temas e mandando seu recado para o maior podcast de segurança do país. Esse conteúdo é gratuito. E você pode contribuir, para que chegue a mais pessoas, tornando-se membro do CT por menos de 1 real por dia: https://ctseguranca.com.br/seja-membro

El futuro de los bosques depende de su protección y de la implementación de iniciativas innovadoras para conservarlos. En este episodio invitamos a Jorge Meza Robayo, representante de FAO en Paraguay, a conversar sobre los retos de los bosques latinoamericanos. Luego, nos trasladamos al Chaco paraguayo y de la mano del periodista Aldo Benitez, de Mongabay Latam, conoceremos a la comunidad indígena Ayoreo Totobiegosode y su experiencia monitoreando los bosques de su territorio ancestral junto a la Federación para la Autodeterminación de los Pueblos Indígenas (FAPI) y Global Forest Watch.

Parlando dinanzi alle Commissioni Finanze di Camera e Senato, nell'ambito dell'indagine sulla riforma dell'irpef, il vice presidente di Confcommercio, Lino Enrico Stoppani, ha affermato che la riforma dell'Irpef, dovrà avere implicazioni sul sistema fiscale nel suo complesso ed essere improntata sulla semplificazione delle norme, in modo da facilitare la ripresa economica del Paese.In una nota ufficiale della FAPI, la Federazione Autonoma delle Piccole Imprese, il Presidente Gino Sciotto chiede al premier Draghi di intervenire con un decreto per differire le prossime scadenze fiscali lasciate in sospeso dal precedente governo, altrimenti tante le piccole e medie imprese rischiano di non farcela.Il biologico resiste alla crisi economica. Nel 2020, la spesa di prodotti alimentari biologici nella Grande Distribuzione Organizzata ha fatto segnare un più 4% rispetto all'anno precedente e il tutto è avvenuto in un contesto di crescita generalizzata delle vendite alimentari in tutti i canali.Le vendite di pelli e pellicce, un settore che è stato motore economico del Canada per trecento anni, sono precipitate del 70% nel 2020, anche a causa della pandemia. Il comparto è costituito da manifattura, commercianti, magazzini e cacciatori e mediamente contribuisce, all'industria del Paese, per circa un miliardo di dollari all'anno, dando lavoro a 60.000 addetti ed a 50.000 cacciatori